“Un avertissement contre l’oubli”

Les reprises, plus fréquemment présentes sur les affiches des théâtres d’années en années nous engagent à penser la question des politiques culturelles et des facteurs économiques qui influent sur les choix de programmation. Nous avons souhaité interroger Emmanuel Wallon sur le cadre socio-économique qui entoure la reprise : la reprise, est-elle un art de la crise ? Une contamination des politiques de programmation par des logiques événementielles ? Le signe d’une patrimonialisation de la cul..

Sources et ressources pour le spectacle vivant (t. 1)

Inventaire des centres et pôles de ressources du spectacle vivant, analyse de leurs fonctionnements et propositions pour développer les services qu\u27ils fournissent en termes de documentation, d\u27information et de conseil

Sources et ressources pour le spectacle vivant

Inventaire des centres et pôles de ressources du spectacle vivant, analyse de leurs fonctionnements et propositions pour développer les services qu\u27ils fournissent en termes de documentation, d\u27information et de conseil

Sources et ressources pour le spectacle vivant (t. 2)

Inventaire des centres et pôles de ressources du spectacle vivant, analyse de leurs fonctionnements et propositions pour développer les services qu\u27ils fournissent en termes de documentation, d\u27information et de conseil

Plos Med

Background The ε4 allele of apolipoprotein E (APOE) gene and increasing age are two of the most important known risk factors for developing Alzheimer disease (AD). The diagnosis of AD based on clinical symptoms alone is known to have poor specificity; recently developed diagnostic criteria based on biomarkers that reflect underlying AD neuropathology allow better assessment of the strength of the associations of risk factors with AD. Accordingly, we examined the global and age-specific association between APOE genotype and AD by using the A/T/N classification, relying on the cerebrospinal fluid (CSF) levels of β-amyloid peptide (A, β-amyloid deposition), phosphorylated tau (T, pathologic tau), and total tau (N, neurodegeneration) to identify patients with AD. Methods and findings This case–control study included 1,593 white AD cases (55.4% women; mean age 72.8 [range = 44–96] years) with abnormal values of CSF biomarkers from nine European memory clinics and the American Alzheimer’s Disease Neuroimaging Initiative (ADNI) study. A total of 11,723 dementia-free controls (47.1% women; mean age 65.6 [range = 44–94] years) were drawn from two longitudinal cohort studies (Whitehall II and Three-City), in which incident cases of dementia over the follow-up were excluded from the control population. Odds ratio (OR) and population attributable fraction (PAF) for AD associated with APOE genotypes were determined, overall and by 5-year age categories. In total, 63.4% of patients with AD and 22.6% of population controls carried at least one APOE ε4 allele. Compared with non-ε4 carriers, heterozygous ε4 carriers had a 4.6 (95% confidence interval 4.1–5.2; p < 0.001) and ε4/ε4 homozygotes a 25.4 (20.4–31.2; p < 0.001) higher OR of AD in unadjusted analysis. This association was modified by age (p for interaction < 0.001). The PAF associated with carrying at least one ε4 allele was greatest in the 65–70 age group (69.7%) and weaker before 55 years (14.2%) and after 85 years (22.6%). The protective effect of APOE ε2 allele for AD was unaffected by age. Main study limitations are that analyses were based on white individuals and AD cases were drawn from memory centers, which may not be representative of the general population of patients with AD. Conclusions In this study, we found that AD diagnosis based on biomarkers was associated with APOE ε4 carrier status, with a higher OR than previously reported from studies based on only clinical AD criteria. This association differs according to age, with the strongest effect at 65–70 years. These findings highlight the need for early interventions for dementia prevention to mitigate the effect of APOE ε4 at the population level

Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

Across multiancestry groups, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson’s disease (PD) and Alzheimer’s disease (AD) versus controls. We demonstrate that the two diseases share the same protective association at the HLA locus. HLA-specific fine-mapping showed that hierarchical protective effects of HLA-DRB1*04 subtypes best accounted for the association, strongest with HLA-DRB1*04:04 and HLA-DRB1*04:07, and intermediary with HLA-DRB1*04:01 and HLA-DRB1*04:03. The same signal was associated with decreased neurofibrillary tangles in postmortem brains and was associated with reduced tau levels in cerebrospinal fluid and to a lower extent with increased Aβ42. Protective HLA-DRB1*04 subtypes strongly bound the aggregation-prone tau PHF6 sequence, however only when acetylated at a lysine (K311), a common posttranslational modification central to tau aggregation. An HLA-DRB1*04-mediated adaptive immune response decreases PD and AD risks, potentially by acting against tau, offering the possibility of therapeutic avenues

"Villes créatives" : la compétition culturelle entre les métropoles

International audienceno abstrac

L'ère des programmateurs, Des centres dramatiques aux scènes publiques, des troupes aux compagnies, du théâtre au spectacle

International audienceno abstrac

Préface

National audienceno abstrac

Quand j'entends le mot "culture", je sors mon vocabulaire : recension de Abécédaire des arts et de la culture, Christian Ruby, L'Attribut, coll. "Culture et Société", Toulouse, 2015, 230 p.

no abstrac